comparemela.com

Latest Breaking News On - Candiolo - Page 1 : comparemela.com

GenFleet Therapeutics Announces Efficacy & Safety Result from Phase II Trial for First-line NSCLC Treatment in KROCUS Study, fulzerasib (KRAS G12C Inhibitor) in Combination with cetuximab, in a Late-breaking Abstract at the Oral Presentation of 2024 ASCO Annual Meeting

Microbot Medical Expands its Physician Support with the Addition of Leading Italian Interventional Radiologist Irene Bargellini, M D , to its Scientific Advisory Board

De-Escalation Has Lasting Benefits for HER2+ Breast Cancers

Scientists discover a new drug-resistance mechanism in breast cancer

Scientists from Università Cattolica in Rome, together with colleagues from the IIGM Foundation (part of Candiolo Institute at Turin), have discovered a new drug-resistance mechanism in breast cancer that leads to the formation of cancer stem cells, (the cells that feed the tumor and cause relapse and metastasis).

Breast cancer, a mechanism of resistance to treatment unveiled

The Italian study suggests a therapy to get around the problem Breast cancer has discovered a drug resistance mechanism that could be undermined in the future with the combination of multiple therapies . This is the promise that comes from the results of a study published in the journal Nature Immunology , conducted between the Catholic University of Rome , and the Italian Institute for Genomic Medicine at Candiolo (Turin).  Research suggests the potential o

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.